Topical analgesics and eye care gains propel OTC topical class

Findings from our upcoming Nonprescription Drugs USA study estimate sales of topical OTC products in the United States at approximately $2.9 billion at the factory level, up 2.9% from 2015 sales levels.


 

 

Manufacturers’ Sales of Topical Products by Product Category, 2016:

SOURCE: Kline’s Nonprescription Drugs USA 2016 study.

The products included in this class span a wide range of categories and are all used to treat skin conditions. Most of the 10 categories in this class post gains in 2016, the highest being the topical analgesics market with strong double-digit growth driven by companies that have launched lidocaine line extensions recently, such as Sanofi and Hisamitsu Pharmaceutical. Eye care products continues to be the largest category in 2016, comprised of artificial tears, ocular decongestants, lubricating ointments, and lid and lash cleaners. OTC eye care products also post strong gains with growth driven by new product launches and increased advertising support from leading companies, such as Allergan and Prestige Brands.

Other large topical brands that posted strong sales growth in 2016 include Neosporin (Johnson & Johnson) first aid brand, Refresh and Refresh Optive (Allergan) eye care brands, Systane (GlaxoSmithKline) eye care brand, Icy Hot and Aspercreme (Sanofi) topical analgesics brands, Salonpas (Hisamitu Pharmaceutical) topical analgesic brand, and Abreva (GlaxoSmithKline) oral care brand.

There is some potential for future switches of OTC topical products in the acne and eczema categories. Differin Gel by Galderma Laboratories entered the OTC acne market in 2016, and additional drugs are poised for future switches in this and other topical OTC categories. See Kline’s upcoming Rx-to-OTC Switch Forecasts USA: Next Frontier study for complete analyses and forecasts of future switches that are expected to enter the acne, eczema, and seven other categories.

Join us for Kline’s free webinar on Key Issues Trending in the OTC Market on Tuesday, June 27, 2017, at 10:30 ET for an in-depth look at the OTC topical products class and many other OTC markets, including probiotics, digestive health, and Rx-to-OTC switches.